oxymetazoline nasal
Selected indexed studies
- Oxymetazoline nasal spray. (Laryngoscope, 1998) [PMID:9707257]
- Epistaxis: Outpatient Management. (Am Fam Physician, 2018) [PMID:30215971]
- How Does Oxymetazoline Change Nasal Aerodynamics and Symptomatology in Patients with Turbinate Hypertrophy? (Laryngoscope, 2024) [PMID:37589314]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Oxymetazoline nasal spray. (1998) pubmed
- Epistaxis: Outpatient Management. (2018) pubmed
- How Does Oxymetazoline Change Nasal Aerodynamics and Symptomatology in Patients with Turbinate Hypertrophy? (2024) pubmed
- Rosacea management: A comprehensive review. (2022) pubmed
- Topical Nasal Decongestant Oxymetazoline: Safety Considerations for Perioperative Pediatric Use. (2021) pubmed
- Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options. (2021) pubmed
- Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours. (2018) pubmed
- Does oxymetazoline increase the efficacy of nasal steroids in treating nasal polyposis? (2016) pubmed
- Hemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in children. (2019) pubmed
- Severe nasal spray oxymetazoline use disorder - a case report. (2026) pubmed